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a b s t r a c t
Paradoxical embolism is considered the major cause of cerebral ischemic events in young
patients. The most common cause of paradoxical embolism, which has been widely
described, is right-to-left shunting (RLS) at cardiac level through a patent foramen ovale
(PFO). Rarely paradoxical embolism can also be caused by RLS at pulmonary level due to
pulmonary arteriovenous ﬁstula (PAVF). Herein, we present a case of a young man, who
experienced transient ischemic attack (TIA) due to paradoxical embolism, in whom both
abovementioned abnormalities coexisted. This coincidence is very rare (noted in only 1% of
patients with cryptogenic stroke or TIA), but it highlights the importance of searching for
extracardiac RLS in patients with cryptogenic stroke, even if a PFO has been detected.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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The incidence of ischemic stroke is strongly correlated with
increasing age. Consequently stroke in children and young
adults is a relatively rare condition and the etiology and risk
factors are different from those of older patients. Paradoxical
embolism associated with intracardiac shunting through a
patent foramen ovale (PFO) is considered the major cause of
cerebral ischemic events in young patients. An often unrecog-
nized cause of paradoxical embolism is intrapulmonary right-
to-left shunting through a pulmonary arteriovenous ﬁstula
(PAVF).
Herein, we present a case of a young man, who experienced
transient ischemic attack (TIA) due to paradoxical embolism,* Corresponding author at: Department of Pediatric Cardiology and Con
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0028-3843/# 2014 Polish Neurological Society. Published by Elsevier Uin whom both abovementioned abnormalities coexisted. This
coincidence is very rare (noted in only 1% of patients with
cryptogenic stroke or TIA), but it highlights the importance of
searching for extracardiac RLS in patients with cryptogenic
stroke, even if a PFO has been detected.
2. Case report
A 15-year-old man, with no previous medical history, experi-
enced two episodes of transient ischemic attacks (TIA) within a
year, which manifested in sudden dysarthria and paresis of the
right upper and lower limb. He was admitted to the Department
of Neurology where his general and neurological examination
was normal. Brain magnetic resonance imaging (MRI) revealedgenital Heart Diseases, Medical University of Gdansk, 7 Debinki St,
rban & Partner Sp. z o.o. All rights reserved.
Fig. 2 – Angiogram showing a single PAVF in the upper lobe
of the right lung.
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atherosclerosis risk factors such as smoking, diabetes or
hyperlipidemia and family history was unremarkable. His
complete coagulation work-up (including Protein S and C levels,
anticardiolipin antibodies, antithrombin, Factor V Leiden,
Prothrombin gene mutation) and carotid ultrasound did not
reveal any abnormalities. Therefore, paradoxical embolism was
suspected. Doppler ultrasound did not reveal any potential
source of embolism in deep veins of the lower limbs as well as in
the iliac veins. However, transcranial Doppler (TCD) showed
right-to-left shunting after saline contrast infusion. The patient
was referred to the Department of Cardiology. On admission, he
had normal physical examination, the oxygen saturation
measured by pulse oximeter was 97%. Holter ecg monitoring
did not reveal any arrhythmia. Transesophageal echocardio-
gram (TEE) showed a small shunt from the left to the right
atrium across the PFO and right-to-left shunting (RLS) with
microbubbles after saline contrast infusion and Valsalva
maneuver. The patient was qualiﬁed for a transcatheter closure
of the patent foramen ovale (PFO). A chest radiography
performed prior to the procedure demonstrated a round shadow
measuring 21 mm  25 mm, located in the upper part of the left
lung (Fig. 1). Contrast enhanced chest computed tomography
(CT) showed a polycyclic mass of uniform density, measuring
20 mm  14 mm and surrounded by feeding vessels located in
the central part of the upper lobe of the left lung. The image
suggested vascular malformation. There was no thrombus
within the PAVF and no evidence of pulmonary embolism.
Under general anesthesia we performed a selective left
pulmonary arterial angiography, which revealed an arteriove-
nous ﬁstula in the upper lobe of left lung (Fig. 2). The diameter of
the vessel supplying the malformation was 7 mm. Occlusion of
the malformation was performed successfully by embolization
using Amplatzer Vascular Plug 10 mm device (Fig. 3). At the
same time PFO closure was performed with Occlutech FigullaFig. 1 – Posteroanterior chest radiograph showing a single
PAVF in the upper part of the left lung (white circle).
Fig. 3 – Angiogram showing complete occlusion of PAVF
with 10 mm Amplatzer Vascular Plug device (arrow).Flex II 23/25 mm device (Fig. 4). The patient was discharged two
days later. There was no recurrence of TIA noted at the 6 months
follow-up and there are no signs of right-to-left shunting in
contrast TCD.
3. Discussion
The most common cause of paradoxical embolism is widely
described right-to-left shunting (RLS) at cardiac level through a
patent foramen ovale (PFO). Our case emphasizes the fact that
other RLS could exist simultaneously and be responsible for
Fig. 4 – Chest radiograph showing two implanted devices:
10 mm Amplatzer Vascular Plug occluding PAVF (black
circle) and Occlutech Figulla Flex II 23/25 mm occluding
PFO (white circle).
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caused by RLS at pulmonary level due to pulmonary
arteriovenous ﬁstula (PAVF). Paradoxical embolism typically
originates in the veins of the lower extremities and occasion-
ally in the pelvic veins. The emboli can be also derived directly
from a local thrombosis within the PAVF [1]. However, due to
the small size of embolic material its certain origin often
remains undetermined.
Pulmonary arteriovenous ﬁstulas are rare pulmonary
vascular malformations with direct communications between
the branches of the pulmonary artery and pulmonary veins.
The incidence of PAVFs is 2–3 per 100 000 population [2]. More
than 80% of PAVFs are congenital, and of these 47–80% are
associated with Osler–Weber–Rendu disease or hereditary
hemorrhagic teleangiectasia (HHT) [3,4]. In contrast to sys-
temic arteriovenous malformation, PAVFs do not affect
cardiac hemodynamics and most patients are asymptomatic
[5]. Rarely, if the right-to-left shunt is large, PAVFs can cause
desaturation and exertional dyspnea, cyanosis, clubbing and
polycythemia [4,6]. Their associated central nervous system
complications include: migraine, transient ischemic attack,
stroke, abscess, and seizures [7]. In one study the reported
incidence of neurological events in patients with PAVFs was
37% for TIA and 18% for stroke [8]. In a different study the
prevalence of cerebral infarction in a single PAVF was 32% and
it increased up to 60% in cases of multiple PAVFs [9]. In a large
scale registry of 642 patients, intrapulmonary shunting was
shown to be an independent predictor of ischemic stroke or
TIA, especially in the group of cryptogenic events.
In young patients with cryptogenic strokes PFOs is detected
by contrast transesophageal echocardiography (c-TEE) and
contrast transcranial Doppler (c-TCD). Contrast-enhanced TEE
with Valsalva maneuver is considered the, gold standard’’ for
revealing PFOs. It is characterized by very high sensitivity andspeciﬁcity. In the case of an extracardiac shunt, the echocar-
diogram will show bubbles entering the left atrium three to eight
cardiac cycles after they were seen in the right atrium [10]. In
contrast, in cardiac RLS, the ‘‘three-beat rule’’ is used, which
means that bubbles should appear between ﬁrst and third
cardiac cycle. In patients with positive contrast echocardiogram
study, but with delayed contrast appearance and no evidence of
interatrial communication, PAVF should be immediately
considered. In well performed TEE examination the ﬂow of
bubbles from the pulmonary vein may also be visualized.
RLS can also be identiﬁed by the use of contrast-enhanced
TCD. The technique is based on the detection of an intrave-
nously injected contrast within intracranial arteries. In case of
an RLS, the contrast enters the arterial circulation and produces
microembolic signals (MES) [11]. Recent studies demonstrate
that TCD is as sensitive as TEE for revealing RLS, but it does not
determine the level of RLS. To distinguish a PFO from a PAVF the
timing of MES appearance in the cerebral circulation during TCD
has been proposed. MES passing pulmonary shunts appear later
in the cerebral circulation than those passing cardiac shunts.
The appropriate diagnostic time window may increase the
speciﬁcity of the test [12]. The time window characteristic for
PAVF is about 15 s (11 s for intracardiac shunts), but it depends
on the heart rate (duration of about 6 heart beats) [11,13].
Classical diagnostic tools to conﬁrm PAVF are contrast
enhanced chest CT or MRI, however pulmonary angiography
is considered the ‘‘gold standard’’. Chest radiography shows
abnormalities in about 45–98% of patients with PAVF, it does not
provide any details, but it may help as a screening tool [14,15].
Most patients with PAVF should be treated. There is evidence
that PAVFs progressively enlarge over time, which is associated
with higher incidence of neurological events [16,17]. It was
shown that recurrences of TIA and strokes occurred more often
in patients with PAVF than with PFO [18]. Apart from preventing
neurological complications occlusion of PAVF protects from
progressive hypoxia and its consequences. Therapeutic options
include percutaneous embolotherapy using coils or vascular
plugs and surgical resection.
In conclusion, our case highlights the importance of
searching for extracardiac RLS in patients with cryptogenic
stroke. The existence of PAVF should be always considered even
if PFO has already been detected. For complete prevention of
recurrent strokes or TIA caused by paradoxical embolism, it is
necessary to not only close a PFO, but all existing shunts.
Conﬂict of interest
None declared.
Acknowledgement and ﬁnancial support
None declared.
Ethics
The work described in this article has been carried out in
accordance with The Code of Ethics of the World Medical
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 6 1 – 6 464Association (Declaration of Helsinki) for experiments involv-
ing humans; Uniform Requirements for manuscripts submit-
ted to Biomedical journals.
r e f e r e n c e s
[1] Abushora MY, Bhatia N, Alnabki Z, Shenoy M, Alshaher M,
Stoddard MF. Intrapulmonary shunt is a potentially
unrecognizes cause of ischemic stroke and transient ischemic
attack. J Am Soc Echocardiogr 2013;26(July (7)):683–90.
[2] Hodgson CH, Keye RL. Pulmonary arteriovenous ﬁstula and
hereditary teleangiectasia. Dis Chest 1963;43:449–55.
[3] Dines DE, Deward JB, Bernatz PE. Pulmonary arteriovenous
ﬁstula. Mayo Clin Proc 1983;58:176–81.
[4] Khurshid I, Downie GH. Pulmonary arteriovenous
malformation. Postgrad Med J 2002;78:191–7.
[5] Prager RL, Law KH, Bender Jr HW. Arteriovenous ﬁstula of
the lung. Ann Thorac Surg 1983;26:231–9.
[6] Majeed FA, Ghumman AQ, Chatha SS. Pulmonary
arteriovenous malformation (PAVM): rare cause of
hemoptysis. J Ayub Med Coll Abbottabad 2013;25:100–2.
[7] Cottin V, Chinet T, Lavole A, Corre R, Marchand E,
Reynaud-Gaubert M, et al. Pulmonary arteriovenous
malformations in hereditary hemorrhagic teleangiectasia:
a series of 126 patients. Medicine (Baltimore) 2007;86:1–17.
[8] White Jr RI, Lynch-Nyhan A, Terry P, Buescher PC,
Farmlett EJ, Charnas L, et al. Pulmonary arteriovenous
malformations: techniques and long-term outcome of
embolotherapy. Radiology 1988;169:663–9.
[9] Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M,
Pollak J, Henderson K, et al. Pulmonary arteriovenous
malformations: cerebral ischemia and neurologic
manifestations. Neurology 2000;55:959–64.[10] Oliveira GHM, Seward BJ, Stanson AW, Swanson JW.
Paradoxical cerebrovascular embolism associated with
pulmonary arteriovenous ﬁstula: contrast
transoesophageal echocardiographic diagnosis. Eur J
Echocardiogr 2001;2:207–11.
[11] Droste DW, Kriete JU, Stypmann J, Castrucci M, Wichter T,
Tietje R, et al. Contrast transcranial Doppler ultrasound in
the detection of right-to-left shunts. Comparison of
different procedures and different contrast agents. Stroke
1999;30:1827–32.
[12] Jauss M, Kaps M, Keberle M, Haberbosch W, Dorndorf W.
A comparison of transesophageal echocardiography and
transcranial Doppler sonography with contrast medium for
detection of patent foramen ovale. Stroke 1994;25:1265–7.
[13] Jauss M, Zanette EM. Detection of right-to-left shunt with
ultrasound contrast agent and transcranial Doppler
sonography. Cerebrovasc Dis 2000;10:490–6.
[14] Kjeldsen AD, Oxhej H, Andersen PE, Green A, Vase P.
Prevalence of pulmonary arteriovenous malformations
(PAVMs) and occurrence of neurological symptoms in
patients with hereditary haemorrhagic telangiectasia
(HHT). J Intern Med 2000;248:255–62.
[15] Sluiter-Eringa H, Orie NGM, Slutier HJ. Pulmonary
arteriovenous ﬁstula: diagnosis and prognosis in
non-complaint patients. Am Rev Respir Dis 1969;
100:177–84.
[16] Puskas JD, Allen MS, Mancure AC. Pulmonary arteriovenous
malformations: techniques and long-term outcome of
embolotherapy. Radiology 1988;169:663–9.
[17] Stringer CJ, Stanley AL, Bates RC, Summers JE. Pulmonary
arteriovenous ﬁstulas. Am J Surg 1955;89:1054–80.
[18] Horner S, Niederkorn K, Gattringer T, Furtner M, Topakian
R, Lang W, et al. Management of right-to-left shunt in
cryptogenic cerebrovascular disease: results from the
observational Austrian paradoxical cerebral embolism trial
(TACET) registry. J Neurol 2013;260:260–7.
